Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transforaminal epidural steroid plus hyaluronic acid versus steroid plus hyaluronidase for lumbar radiculopathy
IRCT20130523013442N39Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Herniated Lumbar Disk, lumbar spinal stenosis (LSS) and lumbosacral radiculopathy comparing Methylprednisolone + hyaluronic acid with Methylprednisolone + hyaluronidase (2 arms). Primary endpoints: Pain assessment and Functional improvement. Started Apr 2026; status: completed.
02
Drugs
methylprednisolonehyaluronic acidhyaluronidase
03
Conditions
Herniated Lumbar Disklumbar spinal stenosis (LSS)lumbosacral radiculopathy
Beyond the preview
Go deeper on IRCT20130523013442N39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130523013442N39.